📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! Tell us what works, what doesn't, and how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community. Please send your feedback to gateway@ukri.org by 11 August 2025.

SARS-CoV-2 rapid antibody test results and subsequent risk of hospitalisation and death in 361,801 people. (2023)

First Author: Whitaker M

Attributed to: MRC Centre for Global Infectious Disease Analysis (MRC GIDA) funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1038/s41467-023-40643-w

PubMed Identifier: 37587102

Publication URI: http://europepmc.org/abstract/MED/37587102

Type: Journal Article/Review

Volume: 14

Parent Publication: Nature communications

Issue: 1

ISSN: 2041-1723